Our innovative sampling tools, services and diagnostics unlock access to accurate, essential information that advances global health and well-being. Our products include molecular sampling kits for the genome and microbiome, cutting-edge services and analytics, rapid diagnostics for infectious disease, and tests for substance abuse.
We are committed to solving the world’s most complex testing challenges. Our legacy of innovation includes first-to-market rapid diagnostics for HIV, Hepatitis C, COVID-19 and Ebola, as well as oral fluid laboratory tests for detecting various drugs of abuse.
We develop easy-to-use and reliable biological sample collection and stabilization devices. Our products maximize sample quality to ensure the highest integrity, from initial collection through downstream analysis.
We accelerate the microbiome industry toward ground-breaking discoveries through our innovative and accurate lab services and state-of-the-art data analytics and reporting.
OraSure Technologies is a global leader in infectious disease diagnostics, and our unique infectious disease assays for HIV, HCV, COVID-19, Ebola, and influenza provide accurate and easy-to-administer testing methods to help healthcare practitioners easily identify infected people.View Infectious Disease Products »
OraSure Technologies is a global leader in oral fluid substance abuse testing products. Our unique assays provide accurate and easy-to-administer testing methods to help determine the presence or absence of drugs or alcohol in a person's system. Oral fluid-based testing products provide a simplified collection process, faster results, and cost savings, with minimal risk of tampering and dramatically reduced risk of adulteration.View Substance Abuse Testing Products »
OraSure Technologies, Inc. has sold its cryosurgical systems business to CryoConcepts, LP. The transaction includes the transfer of OraSure’s professional Histofreezer® product line and several private label cryosurgical products sold in the consumer market, along with related patents and trademarks, customer contracts and goodwill associated with the business.View Histofreezer »
DNA Genotek develops products that optimize ease of collection and provide superior samples and proven performance for those requiring high-quality biological samples for nucleic acid testing. DNA Genotek products are marketed worldwide and support thousands of customers as they achieve breakthroughs in genomic and microbiome research, in diagnostics laboratories, in the pharmaceutical industry, in companion animal genomics and in personalized medicine.Continue to DNAGenotek.com »
Novosanis develops user-friendly and game-changing medical devices that meet all regulatory and quality requirements for self-sampling and drug delivery solutions. The Colli-Pee™ device, designed by Novosanis, efficiently and hygienically captures a volumetric first-void urine sample which is used for improved detection of biomarkers related to urological cancers and sexually transmitted infections.Continue to Novosanis.com »
Diversigen and CoreBiome have created one company that is powering microbiome discovery through sequencing, analysis, and consulting services geared toward the study of the microbiome of living organisms and environments. The combined bench strength of the merged organization is unparalleled in the industry, providing you with access to those who are pioneering advancements in the microbiome field. By working closely with key manufacturers and applying laboratory best practices, Diversigen has developed state-of-the-art techniques to extract high quality nucleic acids from a variety of sample types for subsequent metagenomic analysis. Their flexible sequencing and computing capacity, combined with ongoing improvement of analytic tools and their applications, allow them to customize unique strategies on a per-project basis. Diversigen takes pride in one-on-one consultation with the customer until complete satisfaction is achieved. The services offered cover the full spectrum from organism detection, to analysis, modification, and consultation.Continue to Diversigen.com »